Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Circulatory

  • 1
    News

    VIDEO: Meta-analysis favors anticoagulation for patients with cirrhosis and portal vein thrombosis 

    July 5, 2017

    Anticoagulation has significant benefits and does not increase bleeding risk, regardless of the severity of liver failure.

  • 1
    News

    FDA approves betrixaban for VTE prophylaxis

    June 23, 2017

    An orally administered agent has been approved for VTE prophylaxis in at risk hospitalized patients.

  • 1
    News

    Low-dose aspirin bests dual-antiplatelet therapy in TAVR

    June 8, 2017

    PARIS – ARTE trial is hailed as practice changing.

  • 1
    News

    Infections up the risk for pregnancy-associated stroke in preeclampsia

    May 25, 2017

    A study in a diverse population of pregnant women with preeclampsia has identified several risk factors for pregnancy-associated stroke.

  • 1
    News

    Consider switch to clopidogrel for DAPT early post ACS

    May 20, 2017

    PARIS – TOPIC trial provides new evidence-based DAPT strategy.

  • 1
    News

    Principles learned from a successful improvement program can increase compliance and reduce hospital acquired VTEs (HA-VTEs) across multiple institutions

    May 12, 2017

    Can a single institution’s VTE prophylaxis program be scaled to increase prophylaxis and reduce HA-VTEs across multiple institutions?

  • 1
    News

    Perioperative pharmacological thromboprophylaxis in patients with cancer: a systematic review and meta-analysis

    May 5, 2017

    What are the benefits and harms of perioperative pharmacological thromboprophylaxis in cancer patients undergoing surgery?

  • News

    Guideline for reversal of antithrombotics in intracranial hemorrhage

    April 25, 2017

    Clinical Question: What is the current guideline for reversal of antithrombotics in intracranial hemorrhage (ICH)?

  • 1
    News

    New-onset AF boosts bad HFrEF outcomes

    April 4, 2017

    WASHINGTON – Monitor patients with heart failure with reduced ejection fraction for atrial fibrillation.

  • 1
    News

    Principles learned from a successful improvement program can increase compliance and reduce hospital acquired VTEs (HA-VTEs) across multiple institutions

    March 30, 2017

    Clinical question: Can a single institution's VTE prophylaxis program be scaled to increase prophylaxis and reduce HA-VTEs across multiple institutions?

Previous1 … 21 22 23 24 25Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences